TABLE 2.
Summary of potential uses of multiplex pathogen panels for the diagnosis of viral gastroenteritis
| Clinical scenario | Potential utility of multiplex pathogen testing |
|---|---|
| Uncomplicated inpatient with watery diarrhea | Currently available evidence does not support routine use of syndromic testing |
| Hematologic stem cell transplant recipients | Positive identification of viral pathogen (i.e., norovirus) could prompt reduction in immunosuppression; conversely, a negative result may increase likelihood of alternate noninfectious etiologies (i.e., graft-vs-host disease) |
| Solid organ transplant recipients | Negative results may accelerate timeline to advanced diagnostic techniques (i.e., colonoscopy) and consideration of alternate noninfectious etiologies (i.e., mycophenylate toxicity) |
| Advanced HIV disease | Negative results may accelerate timeline to advanced diagnostic techniques (i.e., colonoscopy) |
| Epidemic response | Rapid identification of an alternate diagnosis can decrease suspicion for a novel/severe pathogen (i.e., SARS-Cov-2, Ebola) |